US Patent Issued to The Johns Hopkins University, Duke University on Feb. 25 for "PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy" (Maryland, Virginia, North Carolina, New York Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,233,137, issued on Feb. 25, was assigned to The Johns Hopkins University (Baltimore) and Duke University (Durham, N.C.).

"PSMA targeted radiohalogenated urea-polyaminocarboxylates for cancer radiotherapy" was invented by Martin G. Pomper (Baltimore), Ronnie C. Mease (Fairfax, Va.), Vivek Kumar (Rensselaer, N.Y.), Sangeeta Ray (Ellicott City, Md.), Michael Zalutsky (Chapel Hill, N.C.) and Ganesan Vaidyanathan (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Small molecule radiohalogenated PSMA inhibitors and metal complexes thereof and their use in radioimaging and radiotherapy for treating PSMA-related diseases, including prostate cance...